BRAIN Biotech AG Cash Flow Quality Index

Latest as of March 2021: -0.98x

BRAIN Biotech AG cash flow quality index. BRAIN Biotech AG (BNN) has a Cash Flow Quality Index of -0.98x as of March 2021. Operating cash flow of €-2.02 Million is below net income of €2.07 Million, suggesting accrual-heavy earnings not yet converted to cash. See BRAIN Biotech AG financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.98x

Operating CF / Net Income

Operating Cash Flow

€-2.02 Million

EUR

Net Income

€2.07 Million

EUR

Data as of

Mar 2021

Most recent filing

BRAIN Biotech AG Cash Flow Quality Index by Year (None–None)

BRAIN Biotech AG cash flow quality index by year from None to None. Year-by-year earnings quality comparison for BRAIN Biotech AG. For the full cash flow conversion analysis, see BRAIN Biotech AG (BNN) cash flow conversion.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.